Andrew Goldsweig to Risk Assessment
This is a "connection" page, showing publications Andrew Goldsweig has written about Risk Assessment.
Connection Strength
1.525
-
Krishna MM, Joseph M, Ezenna C, Pereira V, Rossi R, Akman Z, Rubens M, Mahadevan VS, Nanna MG, Goldsweig AM. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis. Cardiovasc Revasc Med. 2025 Oct; 79:78-89.
Score: 0.142
-
Doma M, Huang W, Hernandez S, Fatima SR, Lingamsetty S, Kritya M, Hemdanieh M, Naji Z, Gewehr DM, Martignoni FV, Goldsweig AM. Immediate transcatheter aortic valve replacement versus temporizing balloon aortic valvuloplasty in severe aortic stenosis: A systematic review and meta-analysis immediate TAVR vs. temporizing BAV. Cardiovasc Revasc Med. 2025 Aug; 77:112-121.
Score: 0.142
-
Ezenna C, Krishna MM, Joseph M, Ibrahim S, Pereira V, Jenil-Franco A, Nanna MG, Bangalore S, Goldsweig AM. Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Interv. 2025 May; 18(5):e015141.
Score: 0.141
-
Ahmad S, Ahsan MJ, Newlun M, Sand M, Rmilah AA, Yousaf A, Shabbir MA, Malik SA, Goldsweig AM. Outcomes of aortic stenosis in patients with cardiac amyloidosis: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Apr; 73:98-106.
Score: 0.140
-
Eid MM, Mostafa MR, Alabdouh A, Najim M, Mohamed S, Ziada AR, Takla A, Balmer-Swain M, Baibhav B, Al-Azizi KM, Goldsweig AM. Short duration of dual antiplatelet therapy following complex percutaneous coronary intervention: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2024 Apr; 61:8-15.
Score: 0.128
-
Ahmad S, Yousaf A, Ghumman GM, Dvalishvili M, Ahsan MJ, Dilibe A, Reis HL, Qavi AH, Szerlip M, Goldsweig AM. Outcomes of transcatheter aortic valve replacement in patients with mitral annular calcification and concomitant mitral valve dysfunction: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2024 Apr; 61:99-109.
Score: 0.127
-
Goldsweig AM, Lyden E, Aronow HD, Kolte D, Pavlides G, Barton D, Chatzizisis Y, Gumina RJ, Abbott JD. Predictors of Contrast Volume in Transcatheter Aortic Valve Replacement. Cardiology. 2020; 145(9):608-610.
Score: 0.101
-
Goldsweig A, Aronow HD. Identifying patients likely to be readmitted after transcatheter aortic valve replacement. Heart. 2020 02; 106(4):256-260.
Score: 0.097
-
Goldsweig AM, Tak HJ, Chen LW, Aronow HD, Shah B, Kolte DS, Velagapudi P, Desai N, Szerlip M, Abbott JD. The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy. Am J Cardiol. 2019 09 01; 124(5):763-771.
Score: 0.094
-
Goldsweig AM, Kennedy KF, Abbott JD, Jones WS, Velagapudi P, Rutar FJ, Curtis JC, Tsai TT, Aronow HD. Patient Radiation Dosage During Lower Extremity Endovascular Intervention. JACC Cardiovasc Interv. 2019 03 11; 12(5):473-480.
Score: 0.093
-
Goldsweig AM, Wang Y, Forrest JK, Cleman MW, Minges KE, Mangi AA, Aronow HD, Krumholz HM, Curtis JP. Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014. Catheter Cardiovasc Interv. 2018 11 15; 92(6):1104-1115.
Score: 0.086
-
Goldsweig AM, Kennedy KF, Kolte D, Abbott JD, Gordon PC, Sharaf BL, Sellke FW, Ehsan A, Sodha NR, Rutar F, Aronow HD. Predictors of patient radiation exposure during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2018 10 01; 92(4):768-774.
Score: 0.085
-
Rao SV, Brooks MM, D'Agostino HEA, Steg PG, Simon T, Aronow HD, Goldsweig AM, Malik S, Alsweiler C, Ho KKL, Dehghani P, Caixeta A, Quraishi AR, Robinson S, Traverse JH, Siddiqi O, Fergusson DA, Potter BJ, Schulman-Marcus J, Keating FK, Carson JL. Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial. Circ Cardiovasc Interv. 2025 May; 18(5):e015249.
Score: 0.035
-
Franco AJ, Krishna MM, Joseph M, Ezenna C, Bakir ZE, Sudo RYU, Wippel CW, Ismayl M, Goldsweig AM, Uthirapathy I. Complete versus culprit-only percutaneous coronary intervention in elderly patients with acute coronary syndrome and multivessel coronary artery disease: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Jan; 70:1-9.
Score: 0.033
-
Singla A, Chobufo MD, Meesum A, Ali A, Aronow WS, Goldsweig AM, Balla S, Whelton PK. Prevalence and outcomes of low ankle brachial index by atherosclerotic cardiovascular disease risk level: Insights from the National Health and Nutrition Examination Survey (NHANES). Am J Med Sci. 2023 02; 365(2):121-129.
Score: 0.030
-
Altin SE, Kim YG, Aronow HD, Armstrong EJ, Goldsweig AM, Dardik A, Lanksy AJ, Mena-Hurtado CI, Abbott JD. Seasonal variation in U.S. hospitalizations for chronic limb-threatening ischemia. Catheter Cardiovasc Interv. 2020 12; 96(7):1473-1480.
Score: 0.026
-
Xie F, Qian L, Goldsweig A, Xu D, Porter TR. Event-Free Survival Following Successful Percutaneous Intervention in Acute Myocardial Infarction Depends on Microvascular Perfusion. Circ Cardiovasc Imaging. 2020 06; 13(6):e010091.
Score: 0.025